LGMD2

Clinical trials for LGMD2 explained in plain language.

Never miss a new study

Get alerted when new LGMD2 trials appear

Sign up with your email to follow new studies for LGMD2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First human test of gene therapy for rare muscle disease begins

Disease control Recruiting now

This study is testing the safety of a single-dose gene therapy called AB-1003 in adults with limb-girdle muscular dystrophy type 2I/R9, a rare genetic muscle disorder. Researchers will give increasing doses to small groups of participants to check for side effects. The goal is to…

Matched conditions: LGMD2

Phase: PHASE1, PHASE2 • Sponsor: AskBio Inc • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

LGMD2

Get alerted when new LGMD2 trials appear

First human test of gene therapy for rare muscle disease begins